drug cost pharma ad pharmaceutical ad

Prescription Drug Costs Are On The Rise; So Are The TV Ads Promoting Them

Laura Ries was moved to action when she saw a TV commercial that portrayed a woman enjoying time with her grandchildren after taking Lyrica,...
Pharmaceutical R&D Investment

Indian IP and Liabilities Law Barrier to Pharmaceutical R&D Investment

Pharmaceutical sector leaders have said that India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US,...
orphan drugs

EMA Backs Three Orphan Drugs

Three of six new meds to be approved in Europe are orphan drugs and have been backed by the European Medicines Agency (EMA) this month. The EMA’s...
tuberculosis

Health Organisations Write to Narendra Modi, Seek Compulsory Licences For Tuberculosis Drugs

Six health organisations and survivors of drug-resistant tuberculosis, health organisations and the TB community have appealed to Prime Minister Narendra Modi to allow issuance...
Glenmark

Glenmark Gets USFDA Nod For Anti-Cholesterol Drug

Drug firm Glenmark Pharmaceuticals today said it has received final approval from the USFDA for its generic version of Fenofibrate capsules used for lowering...
Fosun Pharmaceuticals

FIPB Clears Fosun – Gland Pharma Deal

Shanghai Fosun Pharmaceuticals (Group) Co. Ltd has received approval from Foreign Investment Promotion Board (FIPB) to pick up a majority stake in Hyderabad-based Gland...
Indian pharmaceuticals

Indian Pharmaceuticals M&A Deals Touch $4.6 Billion In 2016

Indian pharmaceuticals sector witnessed 51 deals being announced in the year 2016, with aggregate disclosed deal value of $4.6 billion. Unlike the trend in...
Medherant

Medherant Appoints Laboratoires Plasto Santé as Transdermal Drug Delivery Patch Manufacturer

Coventry, UK, 8th May 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, has...
Ocrevus

USFDA Approved Ocrevus To Treat Multiple Sclerosis

THERAPEUTIC ADVANCE The United States Food and Drug Administration has approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and...
Domain Therapeutics

Domain Therapeutics and Pfizer Inc. enter into collaboration agreement on bioSensAll™

Strasbourg, France, and Montreal, Canada, April 25, 2017 - Domain Therapeutics, a France- and Quebec-based biopharmaceutical company specializing in the research and development of...